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Abstract 
A variety of events, including inhalation of atmospheric chemicals, trauma, and ischemia-reperfusion, may cause generation of 
reactive oxygen species in the lung and result in airways constriction. The specific metabolic mechanisms that translate oxygen radical 
production into airways constriction are yet to be identified. In the lung, calcium homeostasis is central to release of bronchoactive and 
vasoactive chemical mediators and to regulation of smooth muscle cell contractility, i.e., airway constriction. In the present work, we 
characterized Ca2+-transport in the microsomal fraction of mouse lungs, and determined how reactive oxygen species, generated by 
Fe2+/ascorbate and H202/hemoglobin, affected Ca 2+ transport. The microsomal fraction of pulmonary tissue accumulated 90 + 5 nmol 
cae+/mg protein by an ATP-dependent process in the presence of 15 mM oxalate, and 16 + 2 nmol Ca 2÷ in its absence. In the presence 
of oxalate, the rate of Ca 2÷ uptake was 50 + 5 nmol Ca2+/min per mg protein at pCa 5.9 (37°C). The Ca2+-ATPase activity was 50-60 
nmol Pi/min per mg protein (pCa 5.9, 37°C) in the presence of alamethicin. Inhibitors of mitochondrial H+-ATPase had no effect on the 
Ca 2÷ transport. Half-maximal activation of Ca 2÷ transport was produced by 0.4-0.5 /zM Ca 2÷. Endoplasmic reticulurn Ca2+-pump 
(SERC-ATPase) was found to be predominantly responsible for the Ca2+-accumulating capacity of the pulmonary microsomes. 
Incubation of the microsomes in the presence of either Fe2+/ascorbate or H202/hemoglobin resulted in a time-dependent accumulation 
of peroxidation products (TBARS) and in inhibition of the Ca 2÷ transport. The inhibitory effect of Fe2+/ascorbate on Ca 2÷ transport 
strictly correlated with the inhibition of the Ca2+-ATPase activity. These results are the first to indicate a highly active microsomal Ca 2÷ 
transport system in murine lungs which is sensitive to endogenous oxidation products. The importance of this system to pulmonary 
disorders exacerbated by oxidative chemicals remains to be studied. 
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I. Introduction 
Calcium is central to numerous cellular functions. In 
various tissues, including the lung, impairment of mem- 
The opinions and assertations contained herein are the private views 
of the authors and are not to be construed as official nor do they reflect 
the views of the Department of the Army or Department of Defense (AR 
360-5). The experimental studies described in this report adhered to the 
'Guide for the Care and Use of Laboratory Animals', DHEW Publication 
(NIH 85-23). 
* Corresponding author. Fax: + 1 (412) 6241020. 
1 On leave from the Department of Biology, University of Moscow 
(Russia). 
0005-2728/95/$09.50 © 1995 Elsevier Science B.V. All rights reserved 
SSD! 0005-2728(94)00166-9  
brane Ca2+-transport results in tissue injury [1-3]. In the 
lung, calcium homeostasis is central to release of bron- 
choactive and vasoactive chemical mediators and to regu- 
lation of smooth muscle cell contractility, i.e., airway 
constriction [4]. Compounds, such as the Ca2+-ionophore 
A23187, and 2,5-di(tert-butyl)-l,4-benzohydroquinone 
(tBuBHQ), an inhibitor of the Ca 2÷ pump [5], have been 
shown to induce airways constriction [6,7]. Since bron- 
choconstriction i duced by A23187 could be prevented by 
chlorpheniramine, a histamine Hi-antagonist , and by FPL- 
55712, a peptidoleukotriene antagonist, it has been sug- 
gested that histamine and peptidoleukotrienes are the main 
chemical mediators involved in non-immunologically in- 
duced asthma and Ca2+-mediated bronchoconstriction. 
Further, the release of arachidonic acid by phospholipase 
166 E. K Menshikova etaL / Biochimica et Biophysica Acta 1228 (1995) 165-174 
A 2 is a calcium-dependent step of eicosanoid synthesis 
which may be activated by elevated intracellular Ca 2+ [8]. 
Oxidative injury of various pulmonary cells, including 
alveolar macrophages, has been shown to be associated 
with increased intracellular concentrations of Ca 2+ [9-13]. 
The increased Ca 2÷ in both mediator-releasing cells and 
smooth muscle cells may result from inhibition of the 
endoplasmic reticulum Ca2+-pump by oxidants. In aortic 
smooth muscle, myocardium and skeletal muscle, isoforms 
of the intracellular Ca2+-pump (SERC-ATPase) are known 
to be susceptible to reactive oxygen intermediates [14-19]. 
To the best of our knowledge, sensitivity of SERC-ATPase 
to oxidation in the lung has not been studied. The goals of 
this study were to characterize the pulmonary Ca2+-accu- 
mulating activity in a microsomal fraction, and determine 
the sensitivity of the lung SERC-ATPase to oxidative 
stress. 
sterile calcium- and magnesium-free Hanks' balanced salt 
solution (Gibco Laboratories, Grand Island, NY). The fluid 
was withdrawn and cells were isolated by centrifugation at 
600 × g (4°C). Cell pellets were resuspended in 100 /xl 
RPMI 1640/FCS (Whittaker M.A. Bioproduct, Walk- 
ersville, MD) and counted using a hemacytometer. Thus 
obtained lavage fluid contained 0.35 _ 0.03 - 105 cells per 
ml, of which macrophages constituted 95-98%. 
In separate xperiments, tracheas were excised from the 
lung tissue and the tracheal homogenate was prepared. The 
microsomal fraction from the homogenate was then ob- 
tained as above. 
2.2. Measurements of Ca 2 + transport 
Transport of Ca 2+ by lung microsomes was measured 
by three different echniques. 
2. Materials and methods 
2.1. Isolation of lung microsomes 
Male specific pathogen-free Balb/c mice, n = 15, 8-10 
weeks, (26.4 + 1.3 g) were obtained from Hilltop Labora- 
tories (Scottdale, PA) and housed under standard condi- 
tions [20,21]. Animals were anesthetized with sodium 
pentobarbital (80 mg/kg body wt., Beuthanesia-D, Scher- 
ing Corp., USA), and the heart-lungs were immediately 
removed. Lungs were perfused with 0.9% NaCI through 
the pulmonary artery until the lungs were blanched. After 
removing the heart, trachea, and connective tissues, lungs 
were minced (Tissue Tearer, model 989-370, type 2, 
Biospec Products) in 10 volumes of ice-cold medium A 
(20% glycerol, 50 mM KC1, 0,1 mM EDTA, 0.1 mM 
phenylmethylsulfonyl fluoride (PMSF), 10 mM Hepes, pH 
7.2) at 4°C. The tissue suspensions were centrifuged at 
1000 × g for 20 min in a Sorvall RC-5B refrigerated 
centrifuge. The supernatant was saved. The pellet was 
rehomogenized in medium A using Potter-Elvejhem ho- 
mogenizer and recentrifuged at 1000 × g for 20 min. The 
resulting supernatant was combined with the first super- 
natant, filtered through 8 layers of gauze, then centrifuged 
at 10000 X g for 20 min to sediment mitochondria nd 
heavy microsomes. The post-mitochondrial supernatant was 
centrifuged at 105000 × g for 60 min in a Beckman 
Model L7-55 Ultracentrifuge to pellet the microsomal 
fraction. The pellet was resuspended in medium A, without 
PMSF or EDTA and stored at -77°C. The protein content 
of the suspension was determined using the Bio-Rad pro- 
tein assay kit (Richmond, CA) with bovine serum albumin 
as the standard. 
To evaluate the number of alveolar macrophages, mice 
were injected with 0.16 mg/kg atropine (Sigma, St. Louis, 
MO) and 15 min later euthanized with sodium pento- 
barbital. The trachea of animals was infused with 3 x 1 ml 
Chlortetracycline fluorescence 
Ca2÷-accumulation and Ca2÷-release was measured by 
chlortetracycline fluorescence [22] using incubation 
medium containing 100 mM KC1, 1 mM MgC12, 0-25 
/xM CaC12, 1 mM ATP, 5 mM creatine phosphate, 2-3 
IU/ml creatine kinase, 80-120 /zg/ml microsomal pro- 
tein and 10 mM Hepes (pH 6.8 at 28°C) without oxalate 
and containing 10 /xM chlortetracycline [23]. The mea- 
surements were performed on Perkin-Elmer LC-3 spectro- 
fluorimeter at A~x 390 nm and ~em 530 nm in a ther- 
mostated cell, supplied with a vibrator. 
Quin2 fluorescence 
Ca2+-uptake was measured in the presence or in the 
absence of oxalate at different concentrations of free Ca 2 ÷. 
In the presence of oxalate (15 mM) and at 7.6 > pCa < 
6.4, the incubation medium contained 100 mM KC1, 1 mM 
MgCI2, 0-15 /xM CaCI 2, 1 mM ATP, 5 mM creatine 
phosphate, 2-3 IU/ml creatine kinase, 80-120 /zg/ml 
microsomal protein and 10 mM Hepes (pH 6.8 at 28°C) 
and 25 /xM quin2. Ca2+-uptake was assayed by monitor- 
ing time-dependent decrease of quin2 fluoresecence (h~x 
334 nm, /~em 500 nm) [24,25]. 
In the absence of oxalate, Ca2+-uptake by lung micro- 
somes was determined by measuring the fluorescence of 
quin2 in the presence of chlortetracycline. Initially, the 
chlortetracycline fluorescence was recorded as described 
above. At given time intervals, the reaction was stopped by 
adding quin2 (which binds free Ca 2+) and the spectro- 
fluorimeter was adjusted for measurement of quin2 fluo- 
rescence (hex 334 nm, /~em 500 nm). Ca 2÷ uptake was 
determined by the quin2 fluorescence response due to 
alamethicin-induced Ca 2+ release from microsomal vesi- 
cles. Calibration was performed by adding 1-2 nmol of 
CaC12 to the incubation medium (Fig. 1). 
Ca 2 + electrode 
In the presence of oxalate and at high Ca 2 + concentra- 
tions (pCa <6.4), CaZ+-uptake was monitored using 
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Fig. 1. A typical measurement of CaZ+-accumulating capacity of lung 
microsomes using quin2 fluorescence in the presence of chlortetracycline. 
Conditions as described in Section 2. 
Ca2+-selective electrode 93-20 (Orion Research, Cam- 
bridge, MA) [26] in incubation medium containing 15 mM 
oxalate, 100 mM KCI, 1 mM MgC!2, 1 mM ATP, 5 mM 
creatine phosphate, 2-3 IU/ml creatine kinase, 80-120 
/xg/ml microsomal protein and 10 mM Hepes (pH 6.8 at 
28°C). 
2.3. Determination of free Ca 2 + in the incubation medium 
Fluorescence intensity of quin2 was used for calculation 
of the concentration f free Ca 2+ in the incubation medium 
in the range 7.6 < pCa > 6.4. Calculations utilized 115 
nmo1-1 for the dissociation constant of the quin2-Ca 
complex [24]. A CaZ+-selective electrode (Call, Word 
Precision Instruments, New Haven, CT) was used to deter- 
mine the concentration f free Ca 2+ at pCa < 6.4. 
2.4. Ca 2 ÷-ATPase activity 
Ca2+-ATPase activity was measured spectrophotometri- 
cally by monitoring the oxidation of NADH in a coupled 
enzymatic system containing pyruvate kinase plus phos- 
phoenolpyruvate and lactate dehydrogenase plus NADH 
[27]. Measurements were performed in a thermostated cell 
at Area x 340 nm using a Shimadzu UV160U spectro- 
photometer. Total ATPase activity of microsomes was 
measured in the incubation medium containing 130 mM 
NaC1, 20 mM KC1, 3 mM MgC12, 0.4 mM NADH, 0.25 
mM phosphoenolpyruvate, 3 mM ATP, 1 mM CaCI 2, 1 
mM EGTA, pyruvate kinase (2 IU), lactate dehydrogenase 
(6 IU), 5 /.~g/ml alamethicin, 2 /xg/ml oligomycin, 10 
mM Hepes (pH 7.2, 37°C).The basal ATPase activity was 
measured in the same incubation medium without CaC12. 
The Ca2+-dependent ATPase activity was the difference 
between the total activity and the basal activity. 
High intravesicular concentrations of Ca 2÷ (in the mil- 
limolar range) created as a result of active Ca 2÷ transport 
into vesicles are known to inhibit Ca 2 +-ATPase activity of 
microsomes [27,28]. To prevent he Ca 2÷ accumulation, 
A23187 is commonly used [27]. We used alamethicin for 
the measurements of Ca 2 +-ATPase activity of microsomes. 
Alamethicin, a channel-forming antibiotic, has some ad- 
vantage over A23187 in the measurements of Ca 2 ÷-ATPase 
activity, since it not only prevents the Ca 2÷ accumulation 
by microsomes, but also makes membranes permeable to 
ATP and thus accessible to both inside-in and inside-out 
oriented molecules of Ca z +-ATPase [29]. 
2.5. Oxidation systems 
Oxidation was induced by incubation of microsomes 
with ascorbate/Fe(NH4)2(SO4) 2 or hemoglobin/H20 . 
The incubation medium contained 20% glycerol, 50 mM 
KC1, and 3-4 mg/ml microsomal protein in 10 mM 
Hepes (pH 7.0). To initiate oxidation, either 30 /xM 
Fe(NH4)e(SO4) 2 and 0.2 mM ascorbate, or 12.5 /zM 
hemoglobin and 500/xM H202,were added. Fe2+-induced 
oxidation was stopped by EDTA (0.5 mM); hemoglobin- 
induced oxidation was stopped by ascorbate (5.0 mM). In 
both cases the samples were kept on ice before measure- 
ments. 
2.6. ESR measurements of semidehydroascorbyl radicals 
Generation of semidehydroascorbyl radical was moni- 
tored by ESR spectroscopy a JEOL-RE1X spectrometer at 
37°C in gas permeable Teflon tubing (0.8 mm internal 
diameter, 0.0013 mm thickness, Zeuss Industrial Products, 
Raritan, NJ). The tubing was filled with 60 /xl of sample, 
folded into quarters and placed in a open ESR quartz tube 
(3.00 mm internal diameter) in such a way, that all of the 
sample was within the effective microwave irradiation 
area. Spectra were recorded at 335.5 mT center field, 10 
mW power, 0.032 gauss modulation and 2.5 mT/min scan 
time. 
2. 7. Assay of lipid peroxidation by the formation of TBARS 
Lipid peroxidation was measured as the amount of 
2-thiobarbituric acid-reactive substances (TBARS) [30]. 
TBARS were determined from the absorbance at 532 nm, 
using a molar extintion coefficient of 1.56 • 105 M-1 cm-]. 
2.8. Chemicals 
All chemicals used were analytical grade obtained from 
Sigma (St. Louis, MO) unless otherwise noted. Iron am- 
monium sulfate (Fe(NH4)2(SO4) 2) was from Fisher Scien- 
tific Co. (Pittsburgh, PA). Alamethicin, containing peptide 
F30 as the major component, was prepared by V. Ritov 
(Moscow State University, Russia). 
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3. Resu l ts  
3.1. Ca 2 + transport by pulmonary microsomes 
Chlortetracycline, a membrane-permeable fluorescent 
calcium probe, was used to measure Ca 2÷ accumulation by 
the lung microsomal fraction [22,31]. Fluorescence of 
chlortetracycline increased with time upon addition of lung 
microsomes to the incubation medium. A plateau was 
evident by 10 min of incubation (Fig. 2). The time-depen- 
dent increase of fluorescence was not observed in the 
absence of ATP and an ATP-regenerating system. Alame- 
thicin, when added to the incubation medium either prior 
to lung microsomes or after the fluorescent response 
reached a plateau, completely eliminated the ATP-depen- 
dent increase of fluorescence (Fig. 2). These data suggest 
that the lung microsomes are capable of accumulating 
Ca 2+ in an ATP-dependent process. 
Fluorescence of impermeable fluorescent Ca 2÷ probe 
quin2 [24] was used to quantitatively evaluate the Ca 2÷ 
uptake by lung microsomes in the absence of oxalate in 
incubation medium (Fig. 1). Initially, the ATP-dependent 
transport of Ca 2+ was registered as above in the presence 
of chlortetracycline. At given time intervals, quin2 was 
added to the incubation medium which resulted in the 
chelation of free Ca 2+ and the cessation of microsomal 
cae÷-uptake. Determination of Ca 2+ uptake by micro- 
somes was performed by measuring the fluorescence re- 
sponse of quin2 caused by alamethicin-induced Ca2÷ re- 
lease from the vesicles (see Section 2 for details). The 
time-course of ATP-dependent Ca 2÷ transport by lung 
microsomes showed that a plateau was reached within 10 
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Fig. 2. Ca 2+ transport in lung microsomes as measured by chlortetracy- 
cline fluorescence in the presence (1) or in the absence (2) of ATP plus 
ATP-regenerating system. Incubation conditions: incubation medium con- 
tained 100 mM KCI, 1 mM MgCI2, 1 mM ATP, 5 mM creatine 
phosphate, 2-3 IU/ml  creatine kinase, 100 p,g/ml microsomal protein, 
10 /,~M chlortetracycline, and 10 /zM Hepes (pH 6.8 at 28°C). Initial 
concentration of free Ca 2+ was 1 raM. Ca 2+ release from microsomal 
vesicles was induced by addition of alamethicin (5 /xg). 
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Fig. 3. (A) Time-course of Ca 2+ uptake by lung microsomes in as 
measured by quin2 fluorescence. Incubation conditions were as described 
in the legend of Fig. 2. (B) Dependence of the chlortetracycline fluores- 
cence in the course of Ca 2+ transport by microsomes onthe content of 
Ca 2 + accumulated by microsomal vesicles (in the absence ofoxalate). 
min of incubation (Fig. 3). At pCa 5.9 and 28°C lung 
microsomes accumulated 16 + 2 nmol Ca2+/mg protein. 
A linear relationship was found between the time-course of 
chlortetracycline fluorescence r sponse and the time-course 
of Ca 2+ uptake in lung microsomes (Fig. 3B). This sug- 
gests that the rate of the chlortetracycline fluorescence 
increase during Ca 2÷ uptake is determined by Ca 2÷ entry 
into microsomal vesicles and is not limited by the perme- 
ability of membrane for chlortetracycline. 
3.2. Characterization f Ca 2 + transport system in lung 
microsomes 
ATP-dependent transport of Ca 2+ by lung microsomal 
fractions can be accounted for by: (1) a mitochondrial 
contamination, (2) 'inside-out' vesicles of plasma mem- 
branes, and (3) vesicles of endoplasmic reticulum mem- 
branes. To identify potential contributions of each of these 
sources, we studied: (i) the effects of inhibitors of mito- 
chondrial H÷-ATPase, (ii) accessibility of intravesicular 
Ca 2+ to Ca2÷-binding anions, and (iii) sensitivity of Ca 2÷ 
accumulated in vesicles to alamethicin. 
3.3. Effects of inhibitors of mitochondrial H ÷-ATPase 
Inhibitors of mitochondrial H÷-ATPase, oligomycin and 
sodium azide did not affect accumulation of Ca 2 + in lung 
microsomes as measured by quin2 fluorescence (Table 1). 
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Table 1 
Effects of phosphate, oxalate and H+-ATPase inhibitors on Ca 2+ accu- 
mulation by lung microsomes 
Additions Ca 2+ uptake a 
(nmol/mg protein/10 min) 
- 16.7 
NaH2PO 4, 5 mM 34.4 
Potassium oxalate, 5mM 85.1 
Potassium oxalate, 15 mM 93.7 
Sodium azide, 5 mM 16.8 
Oligomycin, 1 /.tg/ml 16.7 
a Measurements of quin2 fluorescence w re performed in the presence of
10 /zM CaCI 2 using 25 /xM quin2 and 15 /xg/ml alamethicin. 
This indicates that mitochondrial Ca2+-transport did not 
contribute to Ca2+-accumulation by lung microsomal vesi- 
cles. 
3.4. Accessibility of  intravesicular Ca 2 + to Ca 2 +-binding 
anions 
Plasma membranes are impermeable for certain anions, 
including Ca2+-binding anions, phosphate and oxalate 
[32,33]. In contrast, intracellular membranes are highly 
permeable for these anions [34,35]. Thus, addition of 
phosphate or oxalate to a suspension of microsomal vesi- 
cles will result in a decrease of intravesicular concentration 
of free Ca 2÷ due to precipitation of insoluble Ca-oxalate 
or Ca-phosphate in the intravesicular space. As a result, 
the Ca2+-accumulating capacity of vesicles will increase. 
In accord with this, the accumulation of Ca 2+ by lung 
microsomes over 10 min incubation increased 2.0- and 
5.0-fold in the presence of phosphate or oxalate, respec- 
tively (Table 1). While these results give a qualitative 
indication of the involvement of intracellular membrane 
vesicles in the CaZ+-uptake by the lung microsomal frac- 
tion, quantitation of the contribution by plasma membranes 
versus intracellular membranes cannot be achieved by 
these measurements. 
To quantify the contribution of plasma membrane 
Ca2+-transport to the overall Ca2+-accumulating activity, 
we studied the effect of oxalate on the chlortetracycline 
fluorescence induced by Ca2+-accumulation. I  the pres- 
ence of oxalate, chlortetracycline fluorescence is expected 
to be quenched ue to precipitation of Ca-oxalate and to 
subsequent decrease of the free Ca 2+ concentration i side 
the vesicles. The quenching effect should depend on the 
amount of oxalate-permeable vesicles in the lung microso- 
mal fraction. Oxalate (15 mM) reduced the Ca2+-induced 
response of chlortetracycline fluorescence by 80% (Fig. 4). 
The oxalate-dependent decrease of chlortetracycline fluo- 
rescence did not result from the inhibition of Ca2+-trans - 
port in the presence of oxalate because under the same 
conditions Ca 2÷ uptake (measured by the alamethicin-in- 
duced quin2 fluorescence increase) was stimulated 5-fold 
by oxalate (Table 1). Based on these measurements, intra- 
IP 3 
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£ 
" 0 ~ t j 
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Microsomes  
Fig. 4. Ca 2+ transport in lung microsomes a measured by chlortetracy- 
cline fluorescence in the absence (1) or in the presence (2) of 15 mM 
potassium oxalate. Ca 2 + release from lung microsomes was induced by 
additions of inositol 1,4,5-trisphosphate (IP3, 5 /zM). 
cellular membrane vesicles are accountable for about 80% 
of the total Ca 2 + transport by lung microsomal fraction. 
3.5. Alamethicin-induced release of  the accumulated Ca 2 + 
Previous studies demonstrated that a peptide antibiotic, 
alamethicin, induces the formation of membrane pores 
[36]. Plasma and intracellular membranes have different 
sensitivity to alamethicin. While low concentrations of 
alamethicin (3-5 /xg/ml) release Ca 2+ from vesicles of 
endoplasmic reticulum, significantly higher concentrations 
of alamethicin (25-50 /zg/ml)  are necessary to release 
Ca 2+ from vesicles of plasma membranes [37]. We took 
advantage of the different sensitivity of plasma and intra- 
cellular membranes to alamethicin, to evaluate their con- 
tent in the lung microsomal fraction. Alamethicin induced 
Ca 2+ release from lung microsomes in a concentration-de- 
pendent manner and the release reached 100% at 5 ~g/ml  
of alamethicin (Fig. 5). This suggests that the lung micro- 
somal fraction did not contain Ca 2+ transporting vesicles 
of plasma membranes. 
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Fig. 5. Dependence of Ca 2+ release from lung microsomal vesicles 
loaded with Ca 2+ on the concentration f alamethicin as measured by 
chlortetracycline fluorescence. Microsomes were incubated for 10 min in 
the absence of oxalate. Other conditions as described inthe legend of Fig. 
2. 
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described inthe legend of Fig. 2. 
3.6. Dependence of Ca 2 + uptake on the concentrations of 
Ca 2 + 
The dependence of the rate of Ca 2+ uptake on the 
concentration of Ca 2+ was measured in the presence of 
oxalate to avoid Ca 2+ leakage from the vesicles in the 
course of Ca 2+ transport. In the range of Ca 2+ concentra- 
tions from pCa 7.6 to 6.4 the measurements were per- 
formed using quin2 fluorescence. At higher Ca 2+ concen- 
trations (pCa < 6.4), Ca2+-selective electrode was em- 
ployed. We found that half-activation of Ca 2+ uptake was 
achieved at Ca z+ concentrations in the range of 0.4-0.5 
/xM (Fig. 6). The rate of Ca 2+ uptake by lung microsomes 
in the presence of 15 mM oxalate and at pCa 5.9 was 
20 + 2 nmol Ca/min per mg protein and 50 + 5 nmol 
Ca/min per mg protein at 28°C and 37°C, respectively. In
microsomes prepared from lavaged lungs (from which 
macrophages were removed), the rate of Ca 2+ uptake at 
0.4/xM Ca 2+ was not significantly different from that in 
microsomes from non-lavaged lungs. This suggests that 
alveolar macrophages do not contribute significantly to 
Ca 2÷ transport by lung microsomes. The rate of Ca 2÷ 
uptake by tracheal microsomes in the presence of oxalate 
(15 mM) at pCa 5.9 (28°C) was 6.8 nmol/min per mg 
protein, i.e., about 3-times lower than the rate of Ca 2+ 
uptake by lung microsomes under these conditions (Fig. 
6). High affinity of the ATP-driven Ca2+-pump to Ca 2÷ 
gives further evidence of the involvement of endoplasmic 
reticulum Ca2+-ATPase (SERC-ATPase) in Ca z+ transport 
by lung microsomes. Direct measurements showed that the 
Ca2+-ATPase activity of lung microsomes in the presence 
of alamethicin was 50-60 nmol Pi/min per mg protein 
(pCa 5.9 at 37°C). 
A 10-15% release of accumulated Ca 2÷ from microso- 
mal vesicles was detected upon addition to the incubation 
medium of 5/zM IP3, a known activator of Ca 2÷ channels 
in endoplasmic reticulum membranes [38] (Fig. 4). Re- 
peated treatment with IP 3 (5 /zM) caused no additional 
release of Ca 2÷. This is indicative of a functional hetero- 
geneity of endoplasmic reticulum Ca 2÷ transporting vesi- 
cles in lung microsomal fraction. 
3.7. Oxidative damage of Ca 2 + transport in lung micro- 
somes 
The SERC-ATPase of muscle tissue is highly sensitive 
to reactive oxygen species [14-19,39]. In this study, we 
investigated the effects of oxidative stress on lung micro- 
somal Ca2+-transport. The lung microsomes were exposed 
to two oxidation systems: (1) Fe2+/ascorbate, and (2) 
hemoglobin/H202 . 
3.8. Effects of Fe 2 +/ascorbate 
Generation of semidehydroascorbyl radical in the course 
of iron-catalyzed oxidation in lung microsomal suspension 
was detected by its typical doublet ESR signal (Fig. 7). 
The semidehydroascorbyl signal decayed over time and 
completely disappeared in 30 min of incubation. Time-de- 
pendent accumulation of lipid peroxidation products was 
found in the course of incubation of microsomes with 
Fe2+/ascorbate (Table 2). 
Incubation of lung microsomes with Fe2+/ascorbate 
induced severe inhibition of microsomal Ca2+-uptake (Fig. 
8). Only 30% of the initial rate of Ca2+-uptake r mained 
after 10 min of incubation of microsomes with 
Fe2+/ascorbate. By the time semidehydroascorbyl radical 
disappeared (30 rain on the ESR spectrum), the rate of 
microsomal Ca 2 +-uptake dropped to zero (Fig. 7, Table 2). 
To estimate the role of the damage of Ca 2 +-ATPase in a 
decreased Ca 2+ transport, he effect of Fe2+/ascorbate on
Table 2 
Effects of Fe2+/ascorbate on Ca 2+ transport and Ca2+-ATPase activity in lung microsomes 
Additions Ca 2+ uptake rate a Ca 2 +-ATPase activity b MDA content 
(nmol/min/mg protein) (nmol Pi/min/mg protein) (nmol/mg protein) 
None (0 min incub.) 6.4 54.7 0.76 
None (30 min 37°C) 5.3 - 1.08 
Fe2+/ascorbate (10 rain 37°C) 2.1 18.9 7.40 
Fe2+/ascorbate (30 min 37°C) 0 0 21.00 
a Ca2+ uptake by microsomes was measured bya decrease offluorescence quin2 in the presence of15 /.tM CaCI2 and 15 mM potassium oxalate. 
b Ca 2 +-ATPase activity was measured spectrophotometrically by oxidation of NADH in coupled enzymatic reactions (for details ee Section 2). 
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Fig. 7. Time-course ofsemidehydroascorbyl radical ESR signal generated 
by oxidation of ascorbate in the presence ofFe 2+ and lung microsomes. 
Incubation conditions: ascorbate (0.2 mM), Fe 2+ (30 /.LM), lung micro- 
somes (4 mg protein/ml) in the medium containing 20% glycerol, 50 
mM KCI, and 10 mM Hepes (pH 6.9 at 37°C). Inset: ESR spectra of 
semidehydroascorbyl radical recorded at different time intervals. 
Ca2+-ATPase activity of lung microsomes was studied. 
Lung microsomes incubated for 10 min with Fe2+/ascor - 
bate retained about 30% of the initial CaE+-ATPase activ- 
ity. No activity of Ca2+-ATPase was revealed after 30 min 
incubation with Fe2+/ascorbate (Table 2). The correlation 
between the extent of inhibition of microsomal Cae+-up - 
take and that of Ca 2 +-ATPase suggests that SERC-ATPase 
may be the target of reactive oxygen species generated by 
Fe2+/ascorbate. 
3.9. Effects of hemoglobin//H202 
High susceptibility of microsomal Ca2+-transport to 
oxidative damage was found in experiments with another 
oxidation system hemoglobin/H20 2. Hemoproteins are 
known to produce ferryl-species upon addition of perox- 
ides [40-42]. In our experiments, n20  2 produced changes 
in the spectrum of methemoglobin, which are characteristic 
of the formation of ferrylhemoglobin [43]. Two absorption 
peaks at 545 and 575 nm appeared in the spectrum of 
methemoglobin (data not shown). Hemoglobin/H20 2 
caused an accumulation of lipid peroxidation products in 
lung microsomes (Table 3). 
Alamethicin 15 pg/ml 
+ 
60-  
i 
C 
1 
~ 2 
E 30-  
E e 3 
0 - r ~ 
Microsomes 5 rain 
Fig. 8. Effect of Fe2+/ascorbate on Ca 2+ transport by lung microsomes. 
Ca 2+ transport was measured by the fluorescence of quin2 in the 
presence ofoxalate (15 raM). Other conditions as described inthe legend 
of Fig. 2. 1, control; 2, 30 min incubation at 37°C in the absence of 
Fe 2+/ascorbate; 3, 10 min incubation i the presence ofFe 2+/ascorbate 
at 37°C; 4, 30 min incubation i the presence ofFe 2+/ascorbate at 37°C. 
Incubation of lung microsomes with hemoglobin/H202 
caused significant inhibition of Ca 2÷ transport by lung 
microsomes (Table 3). After 30 min incubation at 20°C, 
microsomes retained about 50% of the initial Ca2+-trans - 
porting activity (Table 3). The inhibitory effect was insen- 
sitive to an iron chelator, deferoxamine, suggesting that 
ferrylhemoglobin (but not adventitious or released iron) 
was responsible for the decrease of Ca2+-transport. 
4. D iscuss ion  
4.1. Characterization of Ca2 +-transport system in lung 
microsomes 
These studies demonstrated that microsomes obtained 
from mouse lung homogenate accumulated 16 + 2 nmol 
CaE+/mg protein in an ATP-dependent reaction. This is 
2-3-fold higher than the Ca 2+ uptake of similar microso- 
mal fractions from other tissues such as brain (4 nmol 
CaE+/mg protein [37,44]), liver (6 nmol CaE+/mg protein 
[45]) and smooth muscles (5 nmol CaE+/mg protein [46]). 
It is likely that addition of glycerol to the homogenization 
medium improved the stability of microsomal Ca 2+ trans- 
Table 3 
Effects of hemoglobin/H202 on Ca 2+ transport in lung microsomes 
Additions Ca 2+ uptake rate a MDA content 
(nmol/min/mg protein) (nmol/mg protein) 
None (0 min incubation) 8.4 0.8 
None (30 rain 37°C) 7.5 1.1 
Hemoglobin/H202 (30 min 37°C) 3.6 2.3 
Hemoglobin/H202 + desferal (30 min 37°C) 4.4 
a Ca2+ uptake by microsomes was measured by a decrease of fluorescence of quin2 (25 /.tM) in the presence of 15 /zM CaC12 and 15 mM potassium 
oxalate. 
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port during membrane fractionation and/or facilitated the 
separation of Ca2+-transporting vesicles from other mem- 
branes. Our results on microsomes from the lavaged lungs 
and on tracheal microsomes indicate that microsomes from 
alveolar macrophages and tracheal smooth muscle cells are 
not likely to be the major contributors to Ca 2÷ transport in 
lung microsomes. 
Similar to brain microsomes, the microsomal fraction 
from the lung responded to the addition of Ca2+-binding 
anions (phosphate, oxalate) by an enhanced Ca > transport 
[44]. Since permeability o these anions is characteristic of
endoplasmic reticulum membranes, and not of plasma 
membranes, the results indicate that endoplasmic reticulum 
vesicles are involved in the ATP-dependent Ca 2+ transport 
in lung microsomes. To quantify the contribution of endo- 
plasmic reticulum vesicles to overall ATP-dependent Ca 2÷ 
accumulation by lung microsomes we used two ap- 
proaches: (i) the determination f accessibility of intraves- 
icular Ca 2÷ to oxalate, and (ii) the estimation of sensitivity 
of Ca2+-transporting vesicles to alamethicin. 
In endoplasmic reticulum vesicles, which are permeable 
to oxalate, one expects competition of oxalate with chlorte- 
tracycline for the intravesicular Ca 2+, resulting in de- 
creased fluorescence of chlortetracycline. Oxalate would 
not affect the chlortetracycline fluorescence in plasma 
membrane vesicles which are not permeable to oxalate. 
Since we demonstrated an 80% decrease of chlortetracy- 
cline fluorescence in the presence of oxalate, these results 
indicate that at least 80% of the Ca2+-accumulating activ- 
ity in lung microsomal fraction is associated with endo- 
plasmic reticulum membranes. This is likely an underesti- 
mate, since in the presence of 15 mM oxalate a certain part 
of intravesicular Ca 2÷ may still remain complexed with 
chlortetracycline. It is also possible, however, that plasma 
membrane vesicles contribute to Ca 2÷ uptake by the mi- 
crosomal fraction and are not affected by oxalate. 
Our previous tudies demonstrated that low concentra- 
tions of alamethicin release Ca 2÷ solely from vesicles of 
endoplasmic reticulum [37]. In the current study, we found 
that 100% of accumulated Ca 2÷ was released by concen- 
trations of alamethicin as low as 2-5 /zg/ml, which is 
typical of endoplasmic reticulum membranes. 
Taken together, these results suggest hat endoplasmic 
reticulum membranes were solely responsible for the 
Ca2+-accumulating capacity of the pulmonary microsomes. 
However, endoplasmic reticulum membranes from differ- 
ent types of lung cells may constitute the pulmonary 
microsomes which may contain different isoforms of 
Ca2÷-ATPase. 
4.2. Sensitivity of the lung microsomal Ca2+-transport 
system to oxidative stress 
Both enzymatic and non-enzymatic oxidation systems 
have been employed to study the effects of oxidative stress 
on Ca 2+ transport in skeletal and cardiac sarcoplasmic 
reticulum membranes. These oxidation systems include 
Fee+/ascorbate, Fe2+/H202, peroxydisulfate, adri- 
amycin/NADPH, Fe2+/NAD(P)H, and xanthine/ 
xanthine oxidase [14-19]. We used two oxidation systems, 
Fe2+/ascorbate, and hemoglobin/H202, to evaluate the 
sensitivity of the lung microsomal Ca2+-transport tooxida- 
tive stress. Fe2+/ascorbate, a commonly used generator of 
oxygen radicals, has been extensively used to study Ca 2+- 
transport in skeletal and cardiac sarcoplasmic reticulum 
membranes [14,16,17]. Fe 2÷ and ascorbate were shown to 
be released from cells during ischemia-reperfusion episodes 
and are considered to be involved in ischemia-reperfusion 
damage of several tissues [47]. In the presence of H202, 
hemoproteins are known to form ferryl species, which are 
strong oxidants [43,48,49]. Recent studies suggest hat 
myoglobin/H202 may be involved in ischemia-reperfu- 
sion injury of the heart [43]. 
We found that both Ca 2+ transport and Ca2+-ATPase 
activity in lung microsomes were susceptible to reactive 
oxygen species induced by Fe2+/ascorbate or 
hemoglobin/H202. The accumulation of TBARS in the 
presence of hemoglobin/H202 and Fe2+/ascorbate sug- 
gests that lipid peroxidation may be involved in the inhibi- 
tion of Ca 2+ transport due to oxidation-induced increased 
permeability of membranes for Ca 2÷. 
Sensitivity of the lung microsomal Ca 2÷ transport to 
Fe2+/ascorbate-induced damage was comparable to that 
of the skeletal muscle sarcoplasmic reticulum Ca 2 ÷ trans- 
port [14,16]. Fe2+/ascorbate-induced inhibition of Ca 2+ 
transport may be caused by (i) increased permeability of 
membrane to Ca 2÷, (ii) inhibition of Ca2+-ATPase, or (iii) 
a combination of (i) and (ii). In skeletal muscle sarco- 
plasmic reticulum membranes, increased membrane per- 
meability to Ca 2÷ was associated with lipid peroxidation, 
and inhibition of Ca2÷-ATPase was suggested tobe due to 
both accumulation of lipid peroxidation products and di- 
rect oxidation of the Ca2÷-transporting enzyme [14-17]. In 
the current study, inhibition of Ca2+-ATPase paralleled 
inhibition of Ca2+-transport, suggesting that inhibition of 
Ca2+-ATPase was essential for the loss of Ca2÷-accu - 
mulating activity. In contrast, Ca2+-ATPase in skeletal 
muscle sarcoplasmic reticulum was more resistant o 
Fe2+/ascorbate-induced damage, i.e., a complete loss of 
Ca2+-transport occurred prior to any decline of Ca 2÷- 
ATPase activity [14-16]. This difference may reflect dif- 
ferent isoform(s) of Ca2+-ATPase in lung microsomes 
compared with those of skeletal muscle sarcoplasmic retic- 
ulum [50]. Further studies are necessary to determine 
whether different isoforms of Ca 2 +-ATPase exert different 
sensitivity to oxidative stress. 
Reactive oxygen species are suggested tobe involved in 
the mechanism of damage associated with various hemor- 
rhagic lesions of the lung [51-53]. Released hemoglobin 
has been suggested to form an active oxidant, ferrylhe- 
moglobin, in the presence of hydrogen peroxide or organic 
hydroperoxides [43]. Results of the present study suggest 
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that ferrylhemoglobin-mediated damage of the lung may 
be enhanced by an increase in cytoplasmic Ca 2÷ resulting 
from impaired Ca2+-transport by the Ca2+-pump. 
Pulmonary cells are constantly exposed to oxidative 
stress caused by endogenously generated, as well as air- 
borne radicals and reactive oxygen species. Inhalation of 
microorganisms, mineral fibers and particles are known to 
incite pulmonary inflammation resulting in oxidative in- 
jury of lung cells [54-56]. Depletion of antioxidant re- 
serves and accumulation of oxidation products are charac- 
teristic features of inflammatory oxidative lung injury [55]. 
Antioxidants (GSH, N-acetylcysteine, vitamin C, vitamin 
E, dimethylthiourea), antioxidant enzymes (superoxide dis- 
mutase, catalase), inhibitors of radical-producing enzymes 
(allopurinol, imidazole, pyridine), and transition metal 
chelators are all potentially important antioxidant therapeu- 
tics for several inflammatory lung diseases [56]. Airways 
constriction may be associated with generation i the lung 
of reactive oxygen species [56]. The specific metabolic 
mechanisms which translate decreased antioxidant levels 
and enhanced formation of reactive oxygen species to 
airways constriction has yet to be elucidated. 
In model experiments using perfused and ventilated 
guinea pig and rat lungs, hydrogen peroxide induced both 
bronchoconstriction and release of thromboxane A 2 [57]. 
The hydrogen peroxide-induced constriction was abolished 
by iboprufen, a cyclooxygenase inhibitor, and by L- 
670,596, the thromboxane/prostaglandin endoperoxide r - 
ceptor antagonist [57]. These results suggest hat arachi- 
donic acid metabolites participate in hydrogen peroxide-in- 
duced airways constriction. Release of arachidonic acid by 
phospholipase A2-catalyzed reaction is known to be a 
Ca2+-dependent step of eicosanoid synthesis [8,55]. In 
hepatocytes, it has been demonstrated that the oxidant-in- 
duced elevation of the intracellular Ca 2+ concentration 
was insensitive to extracellular Ca 2÷, suggesting release of 
Ca 2+ from intracellular stores [10]. 
Taken together, these data suggest that oxidant-induced 
release of arachidonic acid metabolites and airways con- 
striction may be caused by inhibition of the endoplasmic 
reticulum Ca2+-pump. The present study demonstrates that 
reactive oxygen species are able to inhibit Ca2+-accumulat- 
ing activity of lung microsomes, i.e., block the ability of 
the Ca2+-pump to prevent Ca 2+ release. It follows that the 
oxidant-induced inhibition of the endoplasmic reticulum 
Ca2+-pump may be responsible for the elevated cytosolic 
Ca 2÷, and thus for triggering mediator elease. Direct 
inhibition of the sarcoplasmic reticulum Ca 2+ pump by 
reactive oxygen species should result in elevated intra- 
cellular Ca 2÷ and in smooth muscle cell contractility. 
However, since oxidants may affect other enzymes in- 
volved in the regulation of smooth muscle contractility 
(e.g., guanylate cyclase [58]), further studies are necessary 
to predict heir prevailing effects. 
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